Quadri Meningo Vaccine

generic_icon
Rs.1115for 1 vial(s) (1 ml Injection each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR Quadri Meningo NA Injection

Meningococcal Vaccine (Group A, C, Y & W-135)(NA)

food interaction for Quadri Meningo Injection

alcohol interaction for Quadri Meningo Injection

pregnancy interaction for Quadri Meningo Injection

lactation interaction for Quadri Meningo Injection

food
alcohol
pregnancy
lactation
No interaction found/established
It is not known whether it is safe to consume alcohol with Quadri Meningo Vaccine. Please consult your doctor.
CONSULT YOUR DOCTOR
Quadri Meningo Vaccine is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
SAFE IF PRESCRIBED
Quadri Meningo Vaccine is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
SAFE IF PRESCRIBED

SALT INFORMATION FOR Quadri Meningo NA Injection

Meningococcal Vaccine (Group A, C, Y & W-135)(NA)

Quadri meningo injection uses

{med_name} is used to prevent meningococcal disease.

How quadri meningo injection works

Quadri Meningo Vaccine is a vaccine which helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies (proteins) to protect against any future infections.

Common side effects of quadri meningo injection

Injection site reaction, Sleepiness, Nausea, Headache, Irritation, Muscle pain

SUBSTITUTES FOR Quadri Meningo Injection

No substitutes found

Expert advice FOR Quadri Meningo Injection

  • Meningococcal Vaccine (Group A, C, Y & W-135) is used to prevent meningococcal disease.
  • It is usually given by injection into the muscle of the upper arm.
  • Your doctor will advise you if and when you should receive a booster dose.
  • Immunocompromised individuals or persons suffering from functional or anatomic asplenia (including sickle cell disease) should get it.
  • People travelling to US & Europe, Hajj (as meningococcal meningitis is more prevalent there) are advised to get vaccinated with Meningococcal Vaccine (Group A, C, Y & W-135).

Frequently asked questions FOR Quadri Meningo NA Injection

Meningococcal Vaccine (Group A, C, Y & W-135)

Q. What is Quadri Meningo Vaccine?
Quadri Meningo Vaccine is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Quadri Meningo Vaccine is approved for use in persons aged 2 months through 55 years.
Q. Who should not take Quadri Meningo Vaccine?
Quadri Meningo Vaccine should not be given to patients with known allergy to any other ingredients of this medicine, or any other similar medicines in the past. Signs of an allergic reaction may include an itchy skin rash, shortness of breath and swelling of the face or tongue. If you have had an allergic reaction to any medicine earlier, inform your doctor about it.
Q. Is a booster dose of Quadri Meningo Vaccine needed?
Yes, a single booster dose of Quadri Meningo Vaccine may be administered to individuals aged 15 through 55 years who may be at a continued risk of getting meningococcal disease, if at least 4 years have passed since a prior dose of it was given. If you have any doubts, consult your doctor.
Show More
Q. How is Quadri Meningo Vaccine given?
Quadri Meningo Vaccine is given by a trained healthcare professional or a doctor only and should not be self-administered. Usually, it is given into the muscle of your upper arm, but it may also be given in the thigh muscle in children. Follow your doctor’s instructions carefully to get maximum benefit from Quadri Meningo Vaccine.
Q. Can Quadri Meningo Vaccine cause meningococcal disease?
No. Quadri Meningo Vaccine will not cause meningococcal disease. It just helps your body in producing antibodies against it, so that your body can fight the infection if you are exposed to it in future.

Content on this page was last updated on 29 November, 2023, by Dr. Varun Gupta (MD Pharmacology)